Landi D. Continuation of natalizumab versus interruption is associated with lower risk of relapses during pregnancy and postpartum in women with MS. Abstract 338. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Epstein-Barr-virus en multipele sclerose: een causaal verband?
feb 2022 | Multipele Sclerose, Virale infecties